CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 91 enrolled
Drug / intervention
Platelet Rich Plasma injection to the lumbar facet jointprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04822753
NCT04822753N/ACompleted

A Randomized Placebo-Controlled Trial of Platelet Rich Plasma (PRP) for Facet Mediated Lumbar Low Back Pain

Womack Army Medical Center·interventional·Posted Mar 30, 2021·Updated Jul 11, 2025

In Brief

A clinical study evaluating Platelet Rich Plasma injection to the lumbar facet joint for Facet Joint Pain; Low Back Pain. Completed, enrolled 91 participants across 1 site.

Detailed Summary

Low back pain (LBP) is both the single most common cause of disability and the leading cause of visits when military personnel go to their primary care doctors. Military personnel that deal with LBP can often be placed on limited duty profile. Not surprisingly, the direct and indirect costs of low back and neck pain accounts for approximately $88 billion of health care expenditure. In order to reduce the large financial and personal cost, clinical studies must be designed to treat LBP. This study will provide evidence-based medicine on a new regenerative medicine treatment option that may significantly affect military personnel with LBP. PRP (Platelet Rich Plasma) may offer alternate treatment methods that may help preserve the facet joint structures, and improve pain and function without causing destructive lesions or worsening degenerative joints. This healing process may favor improved participation with rehabilitation therapy and ultimately improve return to duty status. This study will also assess the effectiveness of point of care generated PRP, as a minimally invasive treatment option for treating lumbar facet pain. Specifically, PRP effectiveness will be compared to injecting placebo control when injected into facet joints.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 30, 2021
Enrollment StartSep 29, 2021
Primary CompletionJun 23, 2025
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 5.3 years ago

Interventions

Platelet Rich Plasma injection to the lumbar facet jointprocedure

Using standard fluoroscopic view, place a needle at the target facet joint. Inject about 1ml of study injectate.